Ratings National Health Investors, Inc.

Equities

NHI

US63633D1046

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
62.61 ^USD	-0.38%		+3.59%	+12.10%

Apr. 18	Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting	CI
Mar. 18	Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating	MT

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The group's activity appears highly profitable thanks to its outperforming net margins.
The company is one of the best yield companies with high dividend expectations.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analyst opinion has improved significantly over the past four months.
Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
With a 2024 P/E ratio at 22.05 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The company's "enterprise value to sales" ratio is among the highest in the world.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

	1st Jan change	Capi.	ESG Refinitiv
NATIONAL HEALTH INVESTORS, INC.	+12.10%	2.72B	C-
WELLTOWER INC.	+4.25%	55.56B	A-
VENTAS, INC.	-13.00%	17.46B	A-
HEALTHPEAK PROPERTIES, INC.	-7.37%	13.01B	A
OMEGA HEALTHCARE INVESTORS, INC.	+0.78%	7.63B	B
HEALTHCARE REALTY TRUST INCORPORATED	-16.54%	5.35B	B-
CARETRUST REIT, INC.	+7.02%	3.23B	C-
SABRA HEALTH CARE REIT, INC.	-4.34%	3.16B	C+
AEDIFICA SA	-5.50%	3.02B	B+
MEDICAL PROPERTIES TRUST, INC.	-7.13%	2.76B	C

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes